
Premium tool · $149 session pass
NTAP Analyzer
CMS NTAP Cost Criterion Analyzer™
Test whether a single inpatient stay using your technology clears the CMS New Technology Add-on Payment cost criterion — with device cost converted to gross charges, guidance beside every input and a break-even device price. Want a quick screen first? Try the free Compass threshold check.
How CMS Evaluates the NTAP Cost Criterion
Under CMS regulations (42 CFR § 412.87(b)(3)):
Worked example
If a hospital's baseline stay for that MS-DRG typically bills $120,000 in gross charges, and adding your device adds another $30,000 in billed device charges (device acquisition cost divided by the hospital's implant Cost-to-Charge Ratio), you would enter $150,000 as the average charge per case.
Converting device selling price into gross charges (CCR)
Hospitals bill a marked-up charge for each device, not what they paid you. CMS publishes hospital Cost-to-Charge Ratios (CCRs) in the IPPS Impact File and Provider-Specific File; the implantable devices CCR shows how a hospital's cost relates to its billed charge.
- Selling price $9,000 at a CCR of 0.30 → $9,000 ÷ 0.30 = $30,000 in billed device charges.
- A lower CCR means a higher markup, so the same price produces more charges.
- Use a hospital-specific CCR when you know your target accounts; otherwise test a range (for example 0.25–0.40) to see how sensitive your result is.
Source: CMS Acute Inpatient PPS files, including Table 10 thresholds and impact files.
NTAP Analyzer
Checking your access…
Questions and disclaimer
How long does access last? One payment of $149 includes unlimited checks and Cahir MedTech executive PDF reports during your active session. When you leave the page or close the tab, access ends and a new pass is needed. Downloaded reports remain yours.
Where do I find the MS-DRG threshold? You don't need to look it up—the NTAP Analyzer automatically pre-fills the official CMS threshold when you select an MS-DRG. If you are verifying the figure independently, CMS publishes these values with each annual IPPS Final Rule (traditionally known as Table 10, published as the New Technology Add-On Payment Application Thresholds file, including any correction notices, for the target fiscal year).
Is this reimbursement advice? No. Results are planning estimates; CMS makes the final determination in rulemaking.
Going further? The NTAP Master Guide and Workbook covers the full application, or explore MedTech Compass for hospital-level economics.

